This program contains a suite of breast cancer risk assessment resources, several of which were recently featured in the February 2025 issue of Obstetrics & Gynecology (The Green Journal), to help providers meet hereditary cancer risk assessment guidelines and increase the number of guideline-eligible patients who go on to complete a test.
In a study of five U.S. community OB/GYN practices, clinicians were provided with Myriad Breast Cancer Risk Assessment tools and trained to use them. After eight weeks, results showed the online screening and patient education tools to be extremely effective.
Simply by using the full suite of tools offered, these five clinics more than doubled the percentage of patients who went on to complete hereditary cancer testing.1
16%
completed the test prior to intervention*
34%
completed the test post intervention*
*Of those who met guidelines and were offered testing
Ensure your patients’ hereditary cancer risk factors don’t go undetected. Identify high-risk patients for potentially life-saving screenings with the help of the Myriad Breast Cancer Risk Assessment resources.
Hereditary cancer risk assessment is recommended by the American College of Obstetricians and Gynecologists (ACOG) as a standard part of women’s health care.2
It’s proven to enhance early detection and diagnosis, but there’s often a lack of understanding of genetic testing among patients — and a lack of support for busy clinicians.3
The Myriad Breast Cancer Risk Assessment Program provides you with the resources you need to efficiently identify high-risk patients, educate them on the value of genetic testing, and administer these potentially life-saving tests.
MyGeneHistory®Online screening tool that clearly identifies patients who meet national guidelines for hereditary cancer testing
Pre-Test Patient EducationEducational videos, printed education, and on-demand calls with a Genetic Counselor
Post-Test Patient EducationPatient test results education resources, including consultation with a Genetic Counselor
Clinical Support TeamDedicated clinical support from Myriad Genetic Counselors (GCs) and Medical Science Liaisons (MSLs)
9 out of 10 providers
said the patient education video and speaking to a Genetic Counselor improved patients’ understanding of genetic testing1
7out of 10providers
were able to easily incorporate the video content and other resources into their daily practice1
The Myriad Breast Cancer Risk Assessment Program makes every phase of hereditary breast cancer risk management simpler and more streamlined, including:
You don’t need any specialized genetics expertise to utilize these tools with your patients. And if you do need assistance, Myriad’s board-certified Genetic Counselors and MSLs are available to help you and your patients at any point in the process.
By offering hereditary cancer risk assessment services, you can identify high-risk patients sooner and ensure you’re delivering the standard of care, in compliance with societal best practices.2,4,5,*
*ACOG, NPWH & USPSTF
Fill out the form below to get started.
Request more information about how Myriad’s MyRisk Hereditary Cancer Test can benefit your patients.
Please select one or both options below to learn more about Myriad's Breast Cancer Risk Assessment Program
By submitting your personal information, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in the communication we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Notice.
Contact Information